BHMC

Pre IPO

Blueprint Health Merger Corp.

Raised
$200M
CIK
1847961
Focus
Healthcare, Wellness, Artificial Intelligence, Insurance
External link: SEC Filings

SPAC Team

Leadership

Dr. Rajiv Kumar, our Chief Executive Officer and Director , previously served from 2016 to 2020 as Chief Medical Officer of Virgin Pulse, a private equity-backed software-as-a-service company in the enterprise digital health space, where he was a key member of the executive leadership team and worked closely with the Chief Executive Officer and board of directors on company vision, strategy, and M&A. His responsibilities included serving as President of the Virgin Pulse Institute and leading corporate development, data analytics, and the company’s Science Advisory Board. During his tenure at Virgin Pulse, the company grew to be the dominant player in the employee health and wellbeing industry, reaching approximately $300 million in annual revenue in 2020 and executing on nine M&A transactions totaling nearly $1 billion in enterprise value. Prior to Virgin Pulse, from 2006 to 2016, he was the co-founder and Chief Executive Officer at ShapeUp, a venture capital-backed software-as-a-service company acquired by Virgin Pulse in 2016. Dr. Kumar is a member of the board of directors of Providence Mutual, the nation’s fifth oldest insurance company. He is also an Entrepreneur-in-Residence at Cue Ball Capital, a venture capital firm based in Boston, MA. Dr. Kumar was an early investor and mentor at Blueprint Health, and he continues to invest primarily in digital health companies, leveraging his extensive experience in enterprise software and services. He holds an MD from the Brown University School of Medicine and a BA in business economics also from Brown University. Our board of directors has determined that Dr. Kumar’s healthcare, M&A, private equity, and venture capital experience qualifies him to serve as one of our directors.

Neil Parikh, our Director, will be designated as Vice Chairman of the Board upon the closing of this offering. Mr. Parikh co-founded, and now serves as a Director of, Casper Sleep Inc, which he helped grow from inception in 2014 to IPO. He served as Casper Sleep’s first Chief Operating Officer and subsequently as its Chief Strategy Officer until January 2021. Casper was one of the fastest growing Direct to Consumer brands ever, reaching revenues of $1 million in their first month, $100 million in their first calendar year, and over $1 billion since its inception. Mr. Parikh worked across the business from business development, operations, supply chain, customer service, as well as marketing and public relations. Mr. Parikh has also served as an investor or advisor to 100+ disruptive technology companies including Hyliion (NYSE: HYLN), Relativity Space, Ro, Affirm (NASDAQ:AFRM), Oura, Care/Of, and Simulate Brands. He holds a BA in Commerce, Organizations, and Entrepreneurship from Brown University, where he was Class President. Mr. Parikh is also a co-author of seven patents, ranging from mattresses to robotics. Our board of directors has determined that Mr. Parikh’s entrepreneurial and public company management experience experience qualifies him to serve as one of our directors.

Mathew Farkash, our President , is a founding partner of Blueprint Health, an early-stage healthcare investment firm that has invested in over 80 digital health companies, since 2011. Blueprint Health portfolio companies have raised over $500 million in investment capital and have generated over $2 billion in cumulative enterprise value. At Blueprint Health, he created and managed the Blueprint Health Mentor & Advisor Network, which was a group of 200 healthcare & technology executives and investors who helped accelerate the growth of their portfolio companies and provided access to decision makers across the healthcare industry. Since 2018, Mathew has served as an advisor to Epsilon Health Investors, a healthcare-focused strategic investor, supported by and organized for a consortium of five leading regional not-for-profit health systems across eight states and including 29 hospitals, 450+ non-acute sites of care and $7B+ in net patient revenue. From 2017 to 2018, he served as the Interim Vice President of Strategy and Business Development at Touch Surgery, a Blueprint Health Portfolio Company and helped them raise their private financing rounds and refine and execute their US & global commercial plan prior to their acquisition by Medtronic. Mathew is an international speaker on topics like entrepreneurship, innovation and resiliency in Beirut, Copenhagen and Dubai and visiting faculty member on digital health entrepreneurship at Università della Svizzera italiana. He holds an MBA from NYU Stern School of Business and a BA in Public and Private Sector Organizations from Brown University.

Dr. Brad Weinberg, our Chief Financial Officer and Chief Operating Officer , is a founding partner of Blueprint Health, an early-stage healthcare investment firm that has invested in over 80 digital health companies, since 2011. Blueprint Health portfolio companies have raised over $500 million in investment capital and have generated over $2 billion in cumulative enterprise value. Prior to Blueprint Health, from 2006 to 2011, he was the co-founder and Chief Technology Officer at ShapeUp, a venture capital-backed software-as-a-service company acquired by Virgin Pulse in 2016. Prior to ShapeUp, from 2003 to 2005, he served as a senior investment analyst at the Brown University Endowment. He holds an MD from the Brown University School of Medicine and a BA in business economics also from Brown University. He is a CFA charterholder and a member of the CFA Institute.

Mark Blake, our director nominee , joined S&P Global, Inc. in 2017 as the Global Head of Corporate Development, and became Global Head of Strategy and Corporate Development in early 2020. Mr. Blake previously served as EVP of Corporate Development at Nielsen from 2014 to 2017 and EVP of Strategy and Corporate Development at Cardinal Health from 2009 to 2014. As the enterprise transaction leader of three industry-leading corporations, over the past eleven years Mr. Blake has been involved in nearly 100 acquisitions, investments and divestitures with a total value of more than $50 billion.

In his current role, Mr. Blake is responsible for developing the strategy for overall company growth, sourcing acquisition opportunities, executing transactions and cultivating strategic relationships. He also leads S&P Global Ventures fintech investing for the company. Mr. Blake led the transaction to acquire key ESG assets from RobecoSAM in 2019, was instrumental in the acquisition of artificial intelligence and machine learning provider Kensho in 2018, and played a key role in S&P Global’s recently announced $44 billion merger with IHS Markit.

Mr. Blake has almost a decade of experience in healthcare from his tenure at Cardinal Health, a leading healthcare distributor and services provider, and Medco Health Solutions, a leading pharmacy benefit manager that is now part of Express Scripts. At these companies he completed partnerships and transactions in distribution, sourcing, digital health, and healthcare services.

Mr. Blake’s additional work experience includes turnaround consulting and investment banking. He received a bachelor’s degree in Government from Harvard College and an MBA in Finance and Accounting from the Wharton School of Business. Mr. Blake also serves on the board of WhyHunger, a charitable organization that focuses on addressing the root causes of hunger and food insecurity. Our board of directors has determined that Mr. Blake’s extensive mergers and acquisition and healthcare experience qualifies him to serve as one of our directors.

Richard J. Harrington, our director nominee , is the former President and Chief Executive Officer of The Thomson Reuters Corporation. As CEO from 1997 to 2008, he led its transformation from a diverse newspaper holding company into the leading global provider of online business information, software, and services—including healthcare information services. During his tenure he quadrupled the cash flow and market value of the company and created one of the world’s largest business-to-business information media companies. Mr. Harrington led more than $60 billion in acquisitions and disposals, with two of the most well-known acquisitions being Reuters and Westlaw. He previously held a number of senior leadership positions within Thomson Corporation since 1982.

Mr. Harrington served on the board of directors of Aetna from 2008 to 2018. He also served on the board of directors of Xerox Corporation from 2004 to 2017. During his time at Aetna and Xerox, he was involved in over $100 billion in acquisitions. Mr. Harrington is currently the Chairman Emeritus and Senior Advisor at Cue Ball, a Boston-based venture capital group.

Mr. Harrington has received many honors during his career, including the “Legend in Leadership” award from Yale University, the “CEO of the Year” award from the Executive Council, and the “Man of the Year” award from the National Executive Council for his many philanthropic activities. He was formerly the Chairman of the Thomson Reuters Foundation. He is also a New York Times best-selling co-author of Heart, Smarts, Guts and Luck. Mr. Harrington began his professional career with Arthur Young & Co., where he became a licensed C.P.A. He is a graduate of University of Rhode Island, where he was also awarded an honorary doctorate degree. Our board of directors has determined that Mr. Harrington’s extensive executive leadership, operational, M&A, and public board experience qualifies him to serve as one of our directors.